Privacy Policy
  1. Home
  2. Privacy Policy
Beam Therapeutics, Inc. (NASDAQ: BEAM): Build...
By ACE Investors / 30 Apr 2025
Read More
Anteris Technologies Global Corp. (ASX: AVR):...
By ACE Investors / 30 Apr 2025
Read More
Zoetis Inc (NYSE: ZTS): Expects to Deliver 6%...
By ACE Investors / 24 Apr 2025
Read More
Mayne Pharma Group Limited (ASX: MYX) – Sig...
By ACE Investors / 17 Apr 2025
Read More
Dimerix Limited (ASX: DXB): Executed an exclu...
By ACE Investors / 15 Apr 2025
Read More
CSL Limited (ASX: CSL) – Increase in cash e...
By ACE Investors / 14 Apr 2025
Read More
EXACT Sciences Corporation (NASDAQ: EXAS): Ac...
By ACE Investors / 11 Apr 2025
Read More
Enovis Corp (NYSE: ENOV): Underlying growth f...
By ACE Investors / 10 Apr 2025
Read More
PYC Therapeutics Limited (ASX: PYC) - Multipl...
By ACE Investors / 10 Apr 2025
Read More
Clarity Pharmaceuticals Limited (ASX: CU6): S...
By ACE Investors / 09 Apr 2025
Read More
Resmed Inc. (ASX: RMD): Resmed expanded its g...
By ACE Investors / 08 Apr 2025
Read More
Tempus AI Inc. (NASDAQ: TEM): Closed the fina...
By ACE Investors / 28 Mar 2025
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors